These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 7811242

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Analysis of topoisomerase I and II cleavage sites on the Drosophila actin and Hsp70 heat shock genes.
    Kroeger PE, Rowe TC.
    Biochemistry; 1992 Mar 10; 31(9):2492-501. PubMed ID: 1312349
    [Abstract] [Full Text] [Related]

  • 8. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription.
    Rittner K, Churcher MJ, Gait MJ, Karn J.
    J Mol Biol; 1995 May 05; 248(3):562-80. PubMed ID: 7752225
    [Abstract] [Full Text] [Related]

  • 9. Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome.
    Wong ML, Hsu MT.
    J Virol; 1990 Feb 05; 64(2):691-9. PubMed ID: 2153235
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
    Sawaya BE, Khalili K, Amini S.
    J Gen Virol; 1998 Feb 05; 79 ( Pt 2)():239-46. PubMed ID: 9472608
    [Abstract] [Full Text] [Related]

  • 13. Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II.
    Capranico G, De Isabella P, Tinelli S, Bigioni M, Zunino F.
    Biochemistry; 1993 Mar 30; 32(12):3038-46. PubMed ID: 8384486
    [Abstract] [Full Text] [Related]

  • 14. Drug-specific sites of topoisomerase II DNA cleavage in Drosophila chromatin: heterogeneous localization and reversibility.
    Borgnetto ME, Zunino F, Tinelli S, Kas E, Capranico G.
    Cancer Res; 1996 Apr 15; 56(8):1855-62. PubMed ID: 8620504
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of resistance to drugs that inhibit DNA topoisomerases.
    Beck WT, Danks MK.
    Semin Cancer Biol; 1991 Aug 15; 2(4):235-44. PubMed ID: 1655118
    [Abstract] [Full Text] [Related]

  • 16. In vitro study of functional involvement of Sp1, NF-kappa B/Rel, and AP1 in phorbol 12-myristate 13-acetate-mediated HIV-1 long terminal repeat activation.
    Li Y, Mak G, Franza BR.
    J Biol Chem; 1994 Dec 02; 269(48):30616-9. PubMed ID: 7982981
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of base mutations on topoisomerase II DNA cleavage stimulated by mAMSA in short DNA oligomers.
    Capranico G, Tinelli S, Zunino F, Kohn KW, Pommier Y.
    Biochemistry; 1993 Jan 12; 32(1):145-52. PubMed ID: 8380330
    [Abstract] [Full Text] [Related]

  • 19. The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases.
    Lanza A, Tornaletti S, Stefanini M, Evans HH, Ricanati M, Astaldi Ricotti GC, Pedrini AM.
    Carcinogenesis; 1993 Sep 12; 14(9):1759-63. PubMed ID: 8403196
    [Abstract] [Full Text] [Related]

  • 20. Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid.
    Vlach J, Garcia A, Jacqué JM, Rodriguez MS, Michelson S, Virelizier JL.
    Virology; 1995 Apr 20; 208(2):753-61. PubMed ID: 7747447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.